BioPremiere Inc.

BioPremiere Inc. is a biopharmaceutical company developing novel, and premium biologics for serious diseases. Our candidate drugs, an EPO-lke protein and a TNF inhibitor have a strong IP position, and are both in advanced preclinical development stages.

The BioPremiere team has a strong record of advancing preclinical-stage assets to cinical-stages and clinical proof-of-concept.  Our business model is to de-risk these assets followed by partnering or out-licensing.

News and Events

BioPremiere Inc. has secured the rights for two preclinical-stage biologics.

BioPremiere Inc. has attracted seasoned drug development and regulatory affairs proffesionals.